Introducing GC INK™

Dual action nanotechnology

We have developed a patent pending graphene oxide / silver nanoparticle formulation that is proven to kill viruses, including influenza and coronaviruses. The ink establishes a virucidal layer on fabrics and has been independently tested and certified to have at least 99% virucidal efficacy when applied as a coating to filter material.

Backed up by Data

Brown University, USA conducted an independent study showing that GC Ink kills 100% of coronavirus OC43 and influenza A H1N1 virus in under one minute in liquid form (bioRxiv – Graphene oxide/silver nanoparticle ink formulations rapidly inhibit influenza A virus and OC43 coronavirus infection in vitro, Meredith J. Crane, Stephen Devine, Amanda M. Jamieson, 25th February, 2021).

Further independent tests of GC Ink on filter materials against SARS-CoV-2, the virus that causes COVID-19, shows at least 99% virucidal efficacy when tested on a filter material and show an Mv value (antiviral activity) log reduction of 2.83. These tests have recently been ISO certified (Tests according to ISO 18184:2019, a standard protocol to quantify the antiviral properties of textile materials). Copies of the report are available upon request.

To find out more, please contact us using the form below for our white paper on our GC Ink.

Please complete the form here to request a copy of our whitepaper on GC Ink

How GC INK Works

GC’s technology is highly effective due to its dual action mechanism. The negatively-charged graphene oxide surface traps the positively-charged parts of water droplets and the protein spikes on coronavirus and other viruses. The silver nanoparticles oxidise the lipid membrane protecting coronavirus RNA, thereby killing it.

  • 100% virucidal efficacy on Human Coronavirus OC43 and Influenza A H1N1 viruses in liquid form, in less than one minute. Independently tested by Brown University
  • At least 99% virucidal efficacy on textiles. Independently tested in the UK according to ISO 18184:2019
  • No shedding of GC Ink particles in airflow tests independently tested in the UK, removing toxicity concerns
  • Independent tests confirm no measurable impact on airflow

Indoor Air Quality

There is an acute focus by global government and health institutions on delivering indoor air quality (IAQ) by improving ventilation. While in the past IAQ efforts have focused on reducing indoor air pollutants, the focus is now on reducing exposure to airborne pathogens like SARS-CoV-2.

Ventilation can also exacerbate the problem, where high airflow can foment the spread of pathogens throughout a room and ventilation ducts may carry infectious viruses into connected rooms, such as in schools, hospitals and office buildings – even with good ventilation, infectious viral aerosols from a person with COVID-19 can not only spread throughout that room, but also could migrate from the infected room to uninfected ones through recirculated air.

Cleaning the air of potentially virus-laden aerosols offers long-term benefits for citizen health, support safer work, education and play environments, building confidence with individuals and communities, particularly in areas such as travel, economic and leisure activities.

GC Ink coated pre-filters

The unique ability of GC Ink to form an ultra-thin, uniform, actively virucidal film on the individual fibres of the filter materials, means air can flow virtually unimpeded through treated filters – crucial in building ventilation systems, whilst airborne viruses and bacteria are trapped and destroyed.

Tests by the UK’s National Physical Laboratory (NPL) measuring the impact on airflow rates of applying GC Ink, concluded negligible impact on airflow rates and an independent airflow study has confirmed that there is no shedding of GC Ink particles in airflow tests, addressing toxicity concerns.

GC Ink coated pre-filters can be quickly installed in existing HEPA filters and ventilation systems without the need for retro-fitting – making it a fast, affordable and highly effective solution.

GC Ink™ FAQs

Questions you may have

  • What is GC Ink™?

    GC Ink™ is our patent-pending graphene oxide and silver nanoparticle formulation that establishes a virucidal layer on fabrics and surfaces.

  • How does it work?

    GC Ink™ uses a dual action, ‘trap-and-neutralise’, nanochemistry whereby graphene oxide and silver nanoparticles work together.

    The negatively-charged graphene oxide surface traps water droplets and the protein spikes on coronavirus. The silver nanoparticles neutralise coronavirus by oxidising the membrane that protects the RNA inside.

    All this happens at the nanoscale which makes it more effective. If you’d like to read a detailed scientific explanation of the technology, please refer to the Brown University report.

  • Is it effective?

    Yes. Tests by Brown University have shown that GC Ink™ in liquid form is 100% effective against Human Coronavirus OC43 and Influenza A H1N1 viruses, in less than one minute.

    Independent UK ISO tests on GC Ink™-treated fabric to determine antiviral activity on textiles have also been certified to show at least 99% effectiveness against SARS-CoV-2 according to ISO 18184:2019

  • Is it safe?

    Yes. An independent study by the UK Centre for Process Innovation (CPI) confirms no shedding of GC Ink™ particles in airflow tests of GC Ink™-treated filter materials, removing toxicity concerns. The CPI study used over 20,000 sampling data points to measure particle shedding of GC Ink™ and found none.

    We are preparing for the US Environmental Protection Agency (EPA) approval process, as well as the EU’s Biocidal Products Regulation (BPR) approval process, covering both effectiveness and safety. We are also obtaining International Standards Office (ISO) certifications for product applications.

  • Why did you develop GC Ink™?

    We developed the ink in response to COVID-19. Before the pandemic hit, we were working on a joint project with Brown University to develop a graphene oxide formulation to coat onto clothing that would protect against mosquito bites. We significantly adapted and extended this formulation to protect against coronavirus.

See more

GC feature in The Innovation Platform

Great piece on GC in The Innovation Platform's upcoming publication on all things graphene!  The...

Read more

GC shortlisted in FT’s Tech Champions of 2021!

We are very excited to announce that we have been shortlisted by the Financial Times...

Read more

Major milestone as GC Ink receives ISO 18184 Certification

Exciting news to report - independent ISO tests on our virucidal GC Ink™ shows at...

Read more

Get in touch

Let's talk about building a brighter future together

Please contact us if you are interested in knowing more about our Company, Products or investment opportunities.